M15-538
ClinicalTrials.gov NCT02899052
Research payments
$1,922,269
Through program year 2020, $1,922,269 in research payments was reported against M15-538, across 143 payments, paid by AbbVie, Inc..
- Paid by
- AbbVie, Inc.
- ClinicalTrials.gov
- NCT02899052
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2020 | Research | $835,599 | 75 |
| 2019 | Research | $1,086,670 | 68 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Luciano Costa Birmingham, AL Named on 33 payments
- Jonathan Kaufman Atlanta, GA Named on 19 payments
- Fernando Cabanillas San Juan, PR Named on 18 payments
- Edward Stadtmauer Philadelphia, PA Named on 17 payments
- Tibor Kovacsovics Portland, OR Named on 16 payments
- Andrzej Jakubowiak Chicago, IL Named on 9 payments
- Gregory Monohan Lexington, KY Named on 8 payments
- Michael Thompson Racine, WI Named on 4 payments
- Cristina Gasparetto Durham, NC Named on 4 payments
- Nicholas Burwick Seattle, WA Named on 3 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.